Schedule 13G ownership disclosure

MYMD PHARMACEUTICALS INC

Security class unavailable · CUSIP: 62856X102

Event date: 2022-12-31

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
31,184
Percent of class
2.8500%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000930413-23-000371
Form type
SC 13G/A
Filer
Iroquois Capital Management, LLC
CIK
CIK 1481867
Filed
Feb 14, 2023
Reporting period
Dec 31, 2022
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub